🔎 Trials Near Me

Beranda › Leukemia Mieloid Akut › Florida

Uji klinis Leukemia Mieloid Akut di Florida

55 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi di Florida.

Kota di Florida

Teks studi resmi (Bahasa Inggris)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
  • Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
  • Morton Plant Hospital, Clearwater
  • dan 11 lainnya
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

  • Moffitt Cancer Center, Tampa
Menerima pesertaFase 1
Usia 12 hingga 78 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT03802695

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

  • Miami Cancer Institute, Miami
  • Memorial Hospital West, Pembroke Pines
Menerima pesertaFase 2
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  • Florida Cancer Specialists & Research Institute, Fort Myers
  • Jupiter Research, Jupiter
  • AdventHealth Medical Group Blood & Marrow Transplant at Orlando, Orlando
  • dan 4 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • UF Health Cancer Institute - Gainesville, Gainesville
  • Mayo Clinic in Florida, Jacksonville
  • Miami Cancer Institute, Miami
  • dan 2 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

  • UF Health Cancer Institute - Gainesville, Gainesville
  • Miami Cancer Institute, Miami
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
  • Miami Cancer Institute, Miami
  • Memorial Hospital West, Pembroke Pines
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Mayo Clinic in Florida, Jacksonville
  • Miami Cancer Institute, Miami
  • Memorial Hospital West, Pembroke Pines
Menerima pesertaFase 2
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • UF Health Cancer Institute - Gainesville, Gainesville
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood
  • dan 10 lainnya
Menerima pesertaFase 3
6 Months – 21 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04293562

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06504459

A Study of BGB-11417 in Participants With Myeloid Malignancies

  • Tampa General Hospital, Tampa
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT04771130

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

  • Moffitt Cancer Center, Tampa
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06616636

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

  • Moffitt Cancer Center and Research Institute Hospital, Tampa
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06969430

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • Nemours Children's Clinic-Jacksonville, Jacksonville
  • Nemours Children's Hospital, Orlando
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07022678

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

  • Mayo Clinic, Jacksonville
  • Moffitt Cancer Center, Tampa
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT04588922

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

  • US-Jacksonville FL-MAYOFL, Jacksonville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06652438

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  • US-Orlando FL-ORLANDOHEALTH, Orlando
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07223814

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

  • University of Florida, Gainesville
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Hingga usia 50 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT05322850

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

  • Moffitt Cancer Center, Tampa
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06533761

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • dan 2 lainnya
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05886049

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Broward Health Medical Center, Fort Lauderdale
  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • UF Health Cancer Institute - Gainesville, Gainesville
  • dan 9 lainnya
Menerima pesertaFase 1/2
Hingga usia 22 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

  • Golisano Children's Hospital of Southwest Florida, Fort Myers
  • University of Florida Health Shands Children's Hospital, Gainesville
  • Nemours Children's Specialty Care Jacksonville, Jacksonville
  • dan 2 lainnya
Menerima pesertaFase 3
29 Days – 21 Years · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  • University of Miami, Miami
  • Moffitt Cancer Center & Research Institute, Tampa
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07007312

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

  • H Lee Moffitt Cancer Center & Research Institute, Tampa
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06656494

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

  • University of Miami, Miami
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT07469592

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

  • Bioresearch Partners, Miami
Menerima pesertaFase 2/3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06788756

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

  • Moffitt Cancer Center, Tampa
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT05429632

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

  • University of Miami, Miami
  • AdventHealth Orlando, Orlando
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT05442216

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • Moffitt Cancer Center, Tampa
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Florida Shands Medical Center, Gainesville
  • Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
  • University of Miami (peds), Miami
  • dan 6 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

  • University of Miami Health System, Coral Gables
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT05768932

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

  • University of Florida, Gainesville
Menerima pesertaFase 2
6 Months – 39 Years · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT05800210

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT04256317

Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy

  • University of Miami, Miami
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT06782542

A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

  • Mayo Clinic Florida, Jacksonville
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT05732103

BCL2i CLAG-M in R/R Acute Myeloid Leukemia

  • Moffitt Cancer Center, Tampa
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 1 Apr 2026 · NCT06660368

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

  • Mayo Clinic in Florida, Jacksonville
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Apr 2026 · NCT06279572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • University of Miami, Miami
  • Miami Cancer Institute, Miami
  • Moffitt Cancer Center, Tampa
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT04988555

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.